The pages of this web site article contain an in depth discussion of a new and highly effective neurotransmitter approach to treating without the use of ADD drugs in clinics. This treatment without drugs or drug side effects was developed by NeuroResearch Clinics. While on the surface this approach with no ADD drugs may appear similar to treatment attempted by others in the past, it is differentiated from other approaches by the high degree of effectiveness achieved and the unique way the individual components are used. This approach with no ADD drugs was developed by medical doctors caring for medical patients in their clinics while data basing treatment results. If you need assistance in finding a care giver using the NeuroResearch Clinics approach in treatment without ADD drugs, we can help. ADD drugs In the world of ADD drugs for attention deficit (ADD) there are two groups of drugs prescribed by doctors: Amphetamines Reuptake Inhibitors
Amphetamines are ADD drugs that have multiple chemical properties, they are reuptake inhibitors and they are neurotoxins (cause permanent brain damage). Of concern with prescription drugs is: Amphetamines are neurotoxic. (Adderall, Vyvanse) Reuptake inhibitors deplete neurotransmitters (Concerta, Ritalin, Strattera, Focalin) drugs side effects (see drugs linked below)
ADD drugs The ADD drugs known as "reuptake inhibitors" include Concerta, Ritalin, Strattera and Focalin. These ADD drugs under normal conditions deplete neurotransmitters. The reuptake inhibitor ADD drugs share the problem that they quit working during treatment at some point in time. The reason that the ADD drugs quits working is because drugs that with neurotransmitters do not work if there is not enough neurotransmitters to work with. When the ADD drugs quit working it is because neurotransmitter levels have been depleted, by the drugs, to levels that are too low to keep the drugs working. When one of these drugs quit working the standard approach in medicine is to: Each of the treatment options above, in using ADD drugs in treatment, only serve to deplete neurotransmitter levels in the brain further making the cause of the problem worse. In using ADD drugs in treatment they make the cause of the problem worse, "low neurotransmitter levels". With severe depletion of neurotransmitters the risk of suicide develops. All the ADD drugs used to treat depression and attention deficit (ADD) carries a suicide warning in their prescribing information. For an in depth discussion of how the ADD drugs deplete neurotransmitters and induces suicide risk see the links below. Amphetamines ADD drugs known as Adderall and Vyvanse are amphetamines. All amphetamines are "neurotoxins"' known to cause permanent brain damage. So what does brain damage from amphetamine ADD drugs look like? In the upper left column of this web page is a link titled "The Diseases". Click on it and it will take you to a list of neurotransmitter diseases. These are the diseases that can develop on a chronic basis with ADD drugs use. These diseases usually do not develop while the amphetamine is being taken instead they develop 3 to 5 years after amphetamine ingestion stops. The NeuroResearch Approach Unlike ADD drugs used in treatment, the approach of NeuroResearch Clinics uses nutrients that build neurotransmitters to levels needed for relief of symptoms. The use of nutrients with neurotransmitter testing is a powerful tool and a unique option to ADD drugs. Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa, and cysteine instead of ADD drugs in order to get these results. Proper use of these simple ingredients in medical treatment is not simple. From time to time a patient will say, "Why do I want to take that, I can go to a health food store and buy it?" People off the street buying in a health food store is like going to an art store and buying a bunch of oil paints then going home and expecting to paint like a mater artist even though there was no previous painting experience. These nutrients have tremendous potential due to their chemical properties. This potential is only fully realized in the hands of the trained professional using neurotransmitter testing. Treatment is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control. The Peer Reviewed Research of NeuroResearch Clinics The ADD drugs research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter testing in treatment of depression. | 
